ライフサイエンスコーパス: mice were injected with

1 Six mice were injected with 0.11 nmol of 99mTc-labeled Cy7 tilman

2 he tumors had grown to an average size of 1 cm in diameter, mice were injected with 0.75-2.25 MBq ( approximately 10 mug)

3 C57BL/6 and BALB/c mice were injected with 10 mug of i.p. TDM in light mineral o

4 labeled Cy7 tilmanocept (low-dose group); an additional six mice were injected with 31 nmol of 99mTc-labeled Cy7 tilmanoc

5 ing 24 h for accumulation of the antibody in the tumor, the mice were injected with (64)Cu-NOTA-labeled tetrazine for PET

6 = 3) were injected with a PFC emulsion, and atherosclerotic mice were injected with a saline solution (n = 2).

7 Eight-week-old female (NZW x BXSB)F(1) mice were injected with a single dose of adenovirus expressin

8 RAG1(-/-), B cell(null), and wild-type (WT) mice were injected with a single dose of LCCWE (500 microg/mo

9 ticity of beta-cell mass with respect to age, young and old mice were injected with a single dose of STZ, and beta-cell p

10 mphocyte Bcl-2 overexpression (Bcl-2-Ig) and wild type (WT) mice were injected with a transplantable pancreatic adenocarc

11 Fetal mice were injected with ACK2 on embryonic days 13.5 to 14.5 a

12 To restore Timp3, mice were injected with adenovirus (Ad)-Timp3.

13 Ptk6+/+ and Ptk6-/- mice were injected with azoxymethane alone or in combination

14 At 9-10 months of age, Tg mice were injected with BrdU (100 mg/kg BID) followed by euth

15 to DNFB-induced CHS, severe combined immunodeficient (SCID) mice were injected with CD4(+) T cells, and CD8(+) T cells fr

16 med at 8 weeks after transplantation, when surviving BALB/c mice were injected with CT26 mouse colon cancer cells.

17 ere subjected to sham or BDL for up to 7 days and Kit(W-sh) mice were injected with cultured mast cells or 1x phosphate-b

18 For 12 weeks, mice were injected with doxorubicin, 3 mg/kg/week, or vehicle

19 PC-3 tumor-xenografted BALB/c nu/nu mice were injected with either approximately 13 MBq/250 pmol

20 Wild-type (WT) or TLR2-deficient (TLR2(-/-)) mice were injected with either lipid 654 or lipid 430, and th

21 These transgenic mice were injected with either tamoxifen or vehicle at age 2

22 study, 20 leptin receptor-deficient and three MPO knockout mice were injected with endotoxin (lipopolysaccharide) or fed

23 Neonatal WT and tPA-/- mice were injected with ethanol to mimic FAS in humans.

24 Eyes of C57BL6-SV129 WT and SPARC-null mice were injected with fluorescent microbeads, which were al

25 ponse toward either M1 or M2 macrophages in vivo, wild-type mice were injected with gamma interferon (IFN-gamma) DNA or c

26 Five immunocompetent C57BL/6-cBrd/cBrd/Cr (albino C57BL/6) mice were injected with GL261-luc2 cells, a cell line sharing

27 Corneas of C57BL/6J mice were injected with HAdV-D19p, HAdV-D19 (C), or virus-fre

28 A2(-/-) and A2(+/+) mice were injected with immunoglobulin G (IgG) isolated from

29 ld prevent diabetes onset in NOD mice, nondiabetic NOD/SCID mice were injected with inflammatory T cells from diabetic NO

30 Wild-type or lipoprotein lipase-deficient mice were injected with low-dose D-galactose or PBS subcutane

31 Susceptibility to colitis was restored when the dKO mice were injected with monoclonal antibodies against IL-13,

32 Additionally, mice were injected with MSCs and MAPCs prelabeled with (18)F-

33 Tumor growth was significantly decreased when nude BALB/c mice were injected with Msi1-knockdown BCCs.

34 r-bone microenvironment, the tibias of MMP-7 and MMP-9 null mice were injected with osteolytic luciferase-tagged mammary

35 B6 mice were injected with recombinant mouse IL-33 (rmIL-33) and

36 Additional mice were injected with recombinant murine IL-6 (mIL-6) or ve

37 To further investigate the role of IL-17A, ears of mice were injected with rmIL-23.

38 To test this possibility healthy young Balb/c male mice were injected with serpin B13 mAb or IgG control and exa

39 To determine whether VIP effects were cAMP dependent, mice were injected with small interfering RNA for type 7 aden

40 When mice were injected with staphylococcal enterotoxin B (SEB) su

41 We used a mouse model of sterile necrosis, in which mice were injected with sterile primary necrotic cells, to in

42 s, Sprague-Dawley rats and miR-133a transgenic (miR-133aTg) mice were injected with streptozotocin to induce diabetes.

43 Wild-Type and dominant-negative-DISC1 (DN-DISC1) mice were injected with THC (10 mg/kg) or vehicle for 10 days

44 SCD mice were injected with the anti-P-selectin aptamer, and cell

45 ntial use of VPA to treat muscular dystrophy, mdx/utrn(-/-) mice were injected with the drug.

46 C57BL/6 mice were injected with TNF (5 mug/mouse for 3-6 hours) or ve

47 q, n = 10) or 110 MBq (82-116 MBq, n = 10), whereas control mice were injected with vehicle (n = 10).

48 Postsurgery, the mice were injected with vehicle or FGF23 neutralizing antibod

49 Young male mice were injected with vehicle or recombinant irisin (r-iris

50 C57BL/6 (B6) mice were injected with VIP and mRNA and protein levels, and